These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 35766904)

  • 1. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV).
    Borradori L; Van Beek N; Feliciani C; Tedbirt B; Antiga E; Bergman R; Böckle BC; Caproni M; Caux F; Chandran NS; Cianchini G; Daneshpazhooh M; De D; Didona D; Di Zenzo GM; Dmochowski M; Drenovska K; Ehrchen J; Goebeler M; Groves R; Günther C; Horvath B; Hertl M; Hofmann S; Ioannides D; Itzlinger-Monshi B; Jedličková J; Kowalewski C; Kridin K; Lim YL; Marinovic B; Marzano AV; Mascaro JM; Meijer JM; Murrell D; Patsatsi K; Pincelli C; Prost C; Rappersberger K; Sárdy M; Setterfield J; Shahid M; Sprecher E; Tasanen K; Uzun S; Vassileva S; Vestergaard K; Vorobyev A; Vujic I; Wang G; Wozniak K; Yayli S; Zambruno G; Zillikens D; Schmidt E; Joly P
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1689-1704. PubMed ID: 35766904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines.
    Cozzani E; Marzano AV; Caproni M; Feliciani C; Calzavara-Pinton P;
    G Ital Dermatol Venereol; 2018 Jun; 153(3):305-315. PubMed ID: 29600832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology.
    Feliciani C; Joly P; Jonkman MF; Zambruno G; Zillikens D; Ioannides D; Kowalewski C; Jedlickova H; Kárpáti S; Marinovic B; Mimouni D; Uzun S; Yayli S; Hertl M; Borradori L
    Br J Dermatol; 2015 Apr; 172(4):867-77. PubMed ID: 25827742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV).
    Joly P; Horvath B; Patsatsi Α; Uzun S; Bech R; Beissert S; Bergman R; Bernard P; Borradori L; Caproni M; Caux F; Cianchini G; Daneshpazhooh M; De D; Dmochowski M; Drenovska K; Ehrchen J; Feliciani C; Goebeler M; Groves R; Guenther C; Hofmann S; Ioannides D; Kowalewski C; Ludwig R; Lim YL; Marinovic B; Marzano AV; Mascaró JM; Mimouni D; Murrell DF; Pincelli C; Squarcioni CP; Sárdy M; Setterfield J; Sprecher E; Vassileva S; Wozniak K; Yayli S; Zambruno G; Zillikens D; Hertl M; Schmidt E
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):1900-1913. PubMed ID: 32830877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.
    Schmidt E; Rashid H; Marzano AV; Lamberts A; Di Zenzo G; Diercks GFH; Alberti-Violetti S; Barry RJ; Borradori L; Caproni M; Carey B; Carrozzo M; Cianchini G; Corrà A; Dikkers FG; Feliciani C; Geerling G; Genovese G; Hertl M; Joly P; Meijer JM; Mercadante V; Murrell DF; Ormond M; Pas HH; Patsatsi A; Rauz S; van Rhijn BD; Roth M; Setterfield J; Zillikens D; C Prost ; Zambruno G; Horváth B; Caux F
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):1926-1948. PubMed ID: 34309078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.
    Rashid H; Lamberts A; Borradori L; Alberti-Violetti S; Barry RJ; Caproni M; Carey B; Carrozzo M; Caux F; Cianchini G; Corrà A; Diercks GFH; Dikkers FG; Di Zenzo G; Feliciani C; Geerling G; Genovese G; Hertl M; Joly P; Marzano AV; Meijer JM; Mercadante V; Murrell DF; Ormond M; Pas HH; Patsatsi A; Prost C; Rauz S; van Rhijn BD; Roth M; Schmidt E; Setterfield J; Zambruno G; Zillikens D; Horváth B
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1750-1764. PubMed ID: 34245180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
    Kuhn A; Aberer E; Bata-Csörgő Z; Caproni M; Dreher A; Frances C; Gläser R; Klötgen HW; Landmann A; Marinovic B; Nyberg F; Olteanu R; Ranki A; Szepietowski JC; Volc-Platzer B
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):389-404. PubMed ID: 27859683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
    Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology.
    Santi CG; Gripp AC; Roselino AM; Mello DS; Gordilho JO; Marsillac PF; Porro AM
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):33-47. PubMed ID: 31166405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV).
    Görög A; Antiga E; Caproni M; Cianchini G; De D; Dmochowski M; Dolinsek J; Drenovska K; Feliciani C; Hervonen K; Lakos Jukic I; Kinyó Á; Koltai T; Korponay-Szabó I; Marzano AV; Patsatsi A; Rose C; Salmi T; Schmidt E; Setterfield J; Shahid M; Sitaru C; Uzun S; Valitutti F; Vassileva S; Yayli S; Sárdy M
    J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):1251-1277. PubMed ID: 34004067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pemphigoid diseases in older adults].
    Moderegger EL; Schmitz MJ; Ludwig RJ; Sadik CD; Schmidt E
    Dermatologie (Heidelb); 2023 Sep; 74(9):687-695. PubMed ID: 37594515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial.
    Chalmers JR; Wojnarowska F; Kirtschig G; Mason J; Childs M; Whitham D; Harman K; Chapman A; Walton S; Schmidt E; Godec TR; Nunn AJ; Williams HC
    Health Technol Assess; 2017 Mar; 21(10):1-90. PubMed ID: 28406394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin.
    Pacheco D; Lopes L; Soares-Almeida L; Marques MS; Filipe P
    Acta Dermatovenerol Alp Pannonica Adriat; 2012 Sep; 21(3):59-61. PubMed ID: 23267874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
    Hertl M; Jedlickova H; Karpati S; Marinovic B; Uzun S; Yayli S; Mimouni D; Borradori L; Feliciani C; Ioannides D; Joly P; Kowalewski C; Zambruno G; Zillikens D; Jonkman MF
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):405-14. PubMed ID: 25338479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bullous pemphigoid].
    Schulze F; Kasperkiewicz M; Zillikens D; Schmidt E
    Hautarzt; 2013 Dec; 64(12):931-43; quiz 944-5. PubMed ID: 24337308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology.
    Caux F; Patsatsi A; Karakioulaki M; Antiga E; Baselga E; Borradori L; Caproni M; Cardones AR; Chandran NS; Dräger S; Drenovska K; Goebeler M; Günther C; Hofmann SC; Ioannides D; Joly P; Marinović B; Mariotti EB; Marzano AV; Morel KD; Murrell DF; Prost C; Sárdy M; Setterfield J; Skiljevic D; Uzun S; Vassileva S; Zambruno G; Schmidt E
    J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):1006-1023. PubMed ID: 38421060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous pemphigoid in adolescence.
    Patsatsi A; Kyriakou A; Werth VP
    Pediatr Dermatol; 2019 Mar; 36(2):184-188. PubMed ID: 30569520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interpretation of 2021 French Guidelines for the Therapeutic Management of Bullous Pemphigoid].
    Wang SH; Zuo YG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Oct; 44(5):828-836. PubMed ID: 36325781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based management of bullous pemphigoid.
    Daniel BS; Borradori L; Hall RP; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):613-20. PubMed ID: 21925006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.